wound management technologies, inc., through its subsidiary, wound care innovations, llc, distributes collagen-based wound care products in the united states. the company holds worldwide license to certain technologies and processes related to a collagen-based wound care product formulation under the brand name celleraterx. it markets celleraterx for pressure ulcers, diabetic ulcers, surgical wounds, ulcers due to arterial insufficiency, traumatic wounds, first and second degree burns, and superficial wounds. the company offers celleraterx in gel and powder forms. it serves healthcare providers, such as physicians, clinics, and hospitals. wound management technologies was formerly known as mb software corporation. the company was founded in 1982 and is based in fort worth, texas.
![Sanara MedTech logo](/files/LOGO/714256-SMTI.png)
Company profile
Ticker
SMTI
Exchange
Website
CEO
J. Michael Carmena
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Zimmer Biomet • Enovis • Steris • Intuitive Surgical • Edwards Lifesciences • Avanos Medical • MSA Safety • INVACARE • Align Technology • Surgalign ...
Former names
INAV TRAVEL CORPORATION, MB SOFTWARE CORP, WOUND MANAGEMENT TECHNOLOGIES, INC.
SEC CIK
Corporate docs
Subsidiaries
Cellerate, LLC • Wound Care Innovations, LLC • Sanara Biologics, LLC • Rochal Technologies, LLC • United Wound and Skin Solutions, LLC • Precision Healing, LLC • Pixalere Healthcare USA, LLC • Scendia Biologics, LLC • Sanara MedTech Applied Technologies, LLC • Sanara Collagen Peptides, LLC ...
IRS number
592220004
SMTI stock data
Latest filings (excl ownership)
S-8
Registration of securities for employees
26 Jul 24
8-K
Regulation FD Disclosure
20 Jun 24
8-K
Departure of Directors or Certain Officers
18 Jun 24
8-K
Amendments to Articles of Incorporation or Bylaws
17 Jun 24
EFFECT
Notice of effectiveness
3 Jun 24
8-K
Departure of Directors or Certain Officers
30 May 24
S-3
Shelf registration
21 May 24
DEFA14A
Additional proxy soliciting materials
15 May 24
10-Q
2024 Q1
Quarterly report
13 May 24
8-K
Sanara MedTech Inc. Announces First Quarter 2024 Results
13 May 24
Transcripts
SMTI
Earnings call transcript
2023 Q4
26 Mar 24
SMTI
Earnings call transcript
2023 Q3
14 Nov 23
SMTI
Earnings call transcript
2023 Q2
15 Aug 23
SMTI
Earnings call transcript
2023 Q2
15 Aug 23
SMTI
Earnings call transcript
2023 Q1
16 May 23
SMTI
Earnings call transcript
2022 Q4
21 Mar 23
SMTI
Earnings call transcript
2022 Q3
15 Nov 22
SMTI
Earnings call transcript
2022 Q2
16 Aug 22
SMTI
Earnings call transcript
2022 Q1
17 May 22
SMTI
Earnings call transcript
2021 Q4
31 Mar 22
Latest ownership filings
Financial summary
Quarter (USD) | Mar 24 | Dec 23 | Sep 23 | Jun 23 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 2.83 mm | 2.83 mm | 2.83 mm | 2.83 mm | 2.83 mm | 2.83 mm |
Cash burn (monthly) | 772.99 k | 371.52 k | 510.57 k | 396.27 k | 531.46 k | 258.22 k |
Cash used (since last report) | 2.99 mm | 1.44 mm | 1.97 mm | 1.53 mm | 2.05 mm | 998.31 k |
Cash remaining | -160.27 k | 1.39 mm | 854.30 k | 1.30 mm | 773.55 k | 1.83 mm |
Runway (months of cash) | -0.2 | 3.7 | 1.7 | 3.3 | 1.5 | 7.1 |
Institutional ownership, Q1 2024
0.4% owned by funds/institutions
13F holders | Current |
---|---|
Total holders | 5 |
Opened positions | 4 |
Closed positions | 0 |
Increased positions | 0 |
Reduced positions | 0 |
13F shares | Current |
---|---|
Total value | 899.16 mm |
Total shares | 38.77 k |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
Janney Montgomery Scott | 14.35 k | $531.00 k |
BK Bank Of New York Mellon | 13.08 k | $483.85 mm |
Salem Investment Counselors | 11.21 k | $414.77 mm |
Amalgamated Bank. | 128.00 | $5.00 k |
CWM | 1.00 | $0.00 |
Proequities | 0.00 | $0.00 |
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
12 Jun 24 | Stuckert James W | Common Stock | Grant | Acquire A | No | No | 0 | 3,440 | 0.00 | 840,218 |
12 Jun 24 | Eric D Major | Common Stock | Grant | Acquire A | No | No | 0 | 3,440 | 0.00 | 6,109 |
12 Jun 24 | Sara N Ortwein | Common Stock | Grant | Acquire A | No | No | 0 | 3,440 | 0.00 | 17,522 |
12 Jun 24 | Roszell Mack III | Common Stock | Grant | Acquire A | No | No | 0 | 3,604 | 0.00 | 13,101 |
12 Jun 24 | Tanzberger Eric D | Common Stock | Grant | Acquire A | No | No | 0 | 3,768 | 0.00 | 14,068 |